Plasma stability assays are crucial for evaluating the stability of drug compounds in the bloodstream. By mimicking physiological conditions, these assays determine the degradation rate and metabolic stability of drugs. This information is vital for optimizing drug and predicting in vivo behavior. Plasma stability assays are essential for ensuring drug efficacy and safety, leading to successful a drug discovery program. Find out how Charnwood Discovery can help below: https://lnkd.in/eUDv_EVz #DrugDiscovery #PlasmaStability #adme #dmpk
Charnwood Discovery’s Post
More Relevant Posts
-
It would be an informative conference for people developing oligonucleotide-based therapeutics; the Full agenda is now available. I will give a talk on our experiences with oligonucleotide mediated immune responses. Oligonucleotide Therapeutics Society
⭐ Attention! Full Agenda and Speaker Bios are Now Available for the FDA-CRCG Workshop on Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products on the CRCG website. Join us for this In-Person (+Virtual) event at The Universities at Shady Grove in Rockville, MD on Oct 7-8, 2024. We would love to see you there! Register Today at https://lnkd.in/gpPu_jsf #generics #genericdrugs #Immunogenicity
-
-
🟢 Don't miss out! Our promotion for 15% off our full-length proteins and antibodies ends on February 15! 🟢 Did you know that around 60% of drugs target transmembrane proteins? However, challenges like low expression and purification issues have limited their use. Sino Biological is at the forefront, addressing these challenges. With a focus on multi-pass transmembrane proteins, we've established three innovative platforms – virus-like particles (VLP), detergent micelle, and nanodisc – providing key materials for early-stage drug development. Check out our custom services and range of multipass transmembrane proteins offered, including GPCRs (GPRC5D, CXCR4, SSTR2, CB2), Claudins, and more. https://ow.ly/sNcQ50QysTu #DrugDevelopment #TransmembraneProteins #Promotion
-
-
Peptide Drug Discovery Webinar One Week Away! Register Today: https://buff.ly/4ayEmKy Register today, and join us on Wednesday, Jun 19, 2024 at 10am ET / 7am PT / 4pm CET online to explore peptide drug discovery innovations in your preferred time zone. #Webinar #PeptideDrugDiscovery #PeptideDrugs #SyntheticPeptide #PeptidePlatform #DrugDiscovery
-
-
😊Excited to announce our participation at the prestigious TIDES USA conference in Boston, where top industry leaders come together to discuss advancing Oligonucleotide & Peptide Therapeutics to market. Meet our CMC expert, Paris H., who will be available to share insights on product development, including technical and regulatory support. Let us assist you in achieving your next milestone by offering expertise in all aspects of CMC development. 💊 ❇️What is the appropriate quality of raw materials to be used in the synthesis? ❇️Is our current level of analytical method qualification sufficient for impurity profiling and characterization? ❇️What level of characterization or data (for API/linker/modifications) is needed for the regulatory submission? Meet us: https://lnkd.in/e-TQfP7c Alexandra Beumer Sassi, PhD, RAC, Paris H., Nicole Cohen, Valérie ARNAUDINAUD-LIGNIER, Ioana Venet #TIDESUSA #pharmaconference #marketapprovalacceleration
-
-
In the opportunity-rich but increasingly saturated #GLP1 market, success of new therapies will hinge largely upon: 1) The ability to deliver clear efficacy and safety advantages over existing GLP-1 drugs, and 2) Shortening time-to-market. This article explores high throughput discovery #metabolomics workflows and population-scale #multiomics data can deliver novel biological insights to speed development and differentiate the market positioning of new GLP-1 therapies: https://lnkd.in/gGjDyvJb #glp1therapy #glp1therapies #glp1drug #glp1development
-
In this new Advancing RNA article, BioPhorum demystifies the approaches to manufacturing #mRNA encapsulated in lipid nanoparticles across unit operations for plasmid linearization, drug substance (DS) manufacture, and drug product (DP) manufacture. They include some very helpful flowcharts, too: https://lnkd.in/eTdsc4aT #RNAtherapeutics #RNA #drugmanufacturing
-
-
NOW ON-DEMAND: “Organoid Meets Microelectrode Array (MEA) – Accelerating Drug Discovery and Development” Sven Schönecker, PhD, and Sara Mirsadeghi, MSc, discuss new developments and applications of 3D Mesh Microelectrode Arrays (MEA). Watch it here ⏩ https://bit.ly/3ry2CLT #DrugDiscovery #DrugDevelopment #Pharma #PharmaWebinar
-
Whether it's soothing a headache or a hangover, easing period pains, alleviating muscle aches, or reducing inflammation, ibuprofen is a Non-Steroidal anti-inflammatory drug (NSAID) with "great promise". Join us in examining its various synthesis routes in our video presentation. Delve deeper with our free and exclusive scientific poster. Download it now: https://okt.to/Jet2mo #ibuprofen #pharma #ReferenceStandards #NSAIDs #synthesis
-
Have you seen this one? Teledyne LABS organizes a webinar on Advances in In Vitro Bioequivalence Assessment for Topical Products - IVRT Focus. When? Thursday 17/10/2024, Join us for this instructive webinar providing practical insights you can use immediately in your lab. You’ll discover: ✔ The Principal Goal of Bioequivalence (BE) ✔ Challenges in Topical Generic Drug Development ✔ Current Approaches and Guidelines for BE of Topical Drug Products in the U.S. and E.U. ✔ Role of IVRT Method as Surrogate Alternative and Fundamentals of IVRT ✔ Case Studies Register now: https://lnkd.in/ey-7-adp #IVRT
-
-
Available to watch on-demand: https://buff.ly/45LGcXu #Webinar "New Modality - Peptides Innovations and a Comprehensive Synthetic Peptide Drug Discovery Platform" was presented last month, and the video recording is available online on-demand. #BioDuroSundia #PeptideBasedDrugDiscovery #PeptidesDrugResearch #PeptidesDrugDevelopment #TherapeuticPeptides #PeptideTherapeutics #PeptideSynthesis #Webinar #Presentation #OnDemand #WatchNow
-
